🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objectives of this trial conducted in early Parkinson's Disease (PD) pa...
Status
Completed
Location
248.524.01018 Boehringer Ingelheim Investigational Site
Start Date
2007-05
Trial ID
NCT00479401
Treatments Being Tested
The general aim of this non-interventional study is to assess the safety an...
Status
Completed
Location
Boehringer Ingelheim Investigational Site 1
Start Date
2009-11
Trial ID
NCT01061567
The objectives of the studies are: * To demonstrate similar total exposure...
Status
Completed
Location
Multiple Locations
Start Date
2006-04
Trial ID
NCT02261103
The general aim of this study is to obtain long-term safety and tolerabilit...
Status
Completed
Location
248.633.01004 Boehringer Ingelheim Investigational Site
Start Date
2008-01
Trial ID
NCT00601523
Treatments Being Tested
The study compared pramipexole dihydrochloride extended-release tablets (Te...
Status
Completed
Location
The General Hospital of Western Theater Command PLA
Start Date
2017-03-16
Trial ID
NCT07519278
Bioequivalence between PPX ER 1.5 mg x 1 tablet q.d. and 0.375 mg PPX ER x ...
Status
Completed
Location
248.677.001 Boehringer Ingelheim Investigational Site
Start Date
2010-04
Trial ID
NCT01119443
The general aim of this trial is to determine the efficacy (as measured by ...
Status
Completed
Location
248.525.43005 Boehringer Ingelheim Investigational Site
Start Date
2007-04
Trial ID
NCT00466167
Treatments Being Tested
This is an open-label, prospective post marketing surveillance study to be ...
Status
Completed
Location
Multiple Locations
Start Date
2010-03
Trial ID
NCT01097421
Treatments Being Tested
The objective of this trial is to evaluate non-inferiority of pramipexole E...
Status
Completed
Location
248.671.86004 Boehringer Ingelheim Investigational Site
Start Date
2010-08
Trial ID
NCT01191944
Treatments Being Tested
The general aim of this study is to obtain long-term safety and tolerabilit...
Status
Completed
Location
248.634.43005 Boehringer Ingelheim Investigational Site
Start Date
2007-12
Trial ID
NCT00577460
Treatments Being Tested